MISSOURI VALLEY CANCER CONSORTIUM CCOP

密苏里河谷癌症协会 CCOP

• 批准号: 6376070
• 负责人: JAMES A MAILLIARD
• 金额: $ 44.64万
• 依托单位: CANCER ALLIANCE OF NEBRASKA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-09-30 至 2002-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6376070
• 关键词: behavioral /social science research tag; breast neoplasms; cancer prevention; clinical research; community health services; cooperative study; data management; human subject; human therapy evaluation; neoplasm /cancer education; neoplasm /cancer therapy; patient /disease registry; prostate neoplasms

DESCRIPTION: (Applicant's Description) The Missouri Valley Cancer Consortium (MVCC) is a multi-component community-based cancer research effort based in Omaha and Lincoln, Nebraska. The catchment area includes western Iowa and east-central Nebraska. The 1990 population was about 1.2 million. The MVCC is the third largest accruer of patients to cancer treatment protocols and the second largest to cancer control protocols in the North Central Cancer Treatment Group. The four main components of the MVCC are Alegent Health Bergan Mercy Medical Center, Alegent Health Immanuel Medical Center, Lincoln Cancer Center, and Creighton University. These institutions have had an established research program with the North Central Cancer Treatment Group (NCCTG) since 1983. Numerous investigators (52) participate and are responsible for over 3200 new cancer patients annually. Over the past 2 years of the previous funding period, these investigators have entered 201.1 and 223.4 patients on NCI-approved cancer treatment and control trials, respectively. The proposed principal and associate principal investigators of the MVCC are currently directing the conduct of the Breast Cancer Prevention Trial and the Prostate Cancer Prevention Trial (837 enrolled and 639 randomized for the state of Nebraska. Previous research base affiliations with NCCTG, ECOG, and NSABP would continue with the addition of RTOG and GOG and enable the future support of this high level of accrual as a NCI-funded CCOP.

描述：（申请人描述）密苏里州山谷癌症 联盟（MVCC）是一个多组成部分的社区为基础的癌症研究 位于奥马哈和内布拉斯加州的林肯。 集水区包括 位于爱荷华州西部和内布拉斯加州中东部。 1990年人口约为1.2 万 MVCC是癌症治疗患者的第三大累积者 北半球第二大癌症控制协议 中央癌症治疗小组。 MVCC的四个主要组成部分是 Alegent Health Bergan Mercy医疗中心，Alegent Health Immanuel Medical 中心，林肯癌症中心和克雷顿大学。 这些机构 在北中央癌症研究中心有一个既定的研究项目， 治疗组（NCCTG）自1983年以来。 许多研究者（52名）参与 每年有超过3200名新的癌症患者。 来 在上一个资助期的过去两年中，这些研究人员 入组了201.1和223.4例接受NCI批准的癌症治疗的患者， 对照试验。 建议的主要和联营公司 MVCC的主要调查员目前正在指导进行 乳腺癌预防试验和前列腺癌预防试验 (837在内布拉斯加州，639人被随机分配。 先前 与NCCTG、ECOG和NSABP的研究基地关系将继续， 增加RTOG和GOG，并使未来的支持这一高 作为国家投资机构供资的CCOP的应计水平。